Partnerships reshape outcomes. Nicole Richie of Genentech shows how Inclusive Research Site Alliances expand outreach, boost diverse enrollment, and expose design flaws that quietly exclude. Inclusion isn’t a checkbox. It’s a redesign.
👉 shorturl.at/KYmHH
Who gets left out today?

#InclusiveResearch

Want to make medical education more personal, accessible, and trusted? Georgia Spain, AstraZeneca’s Director of Global Oncology Digital Innovation, explores how HCPs engage and what we might be overlooking.

👉Learn more in person this October:
shorturl.at/r7Dmk

#REcustomerEU #MedicalEducation

Launch strategy isn’t just about what you say, it’s how you say it.
Patients need empathy. HCPs need trust. Payers need proof. Advocates need vision.
Learn how to tailor messaging across the board, full rec: bit.ly/3IKdKP2

Which audience do you think gets overlooked?

#MedicalAffairs #PharmaLaunch

Clinical trials can miss what matters most. Melody Joy Paine shares a Rett syndrome story that asks: what if lived experience guided how we assess impact? Not everything that counts can be measured.

👉Access the full webinar > shorturl.at/gWBgW

#ClinicalTrials #PatientCentricity

“Who is the payer, how do they decide, and who influences them?” - Yvette Venable on tailoring payer-focused messaging.

👉Watch the full session: bit.ly/3KAc4bk

#MarketAccess #PayerStrategy #Pharma #HealthEconomics #ValueCommunication

Impact-weighted networks + social listening + machine learning = faster, smarter KOL discovery.
Watch the full webinar for fresh thinking on how data science is reshaping medical influence mapping.
👉 shorturl.at/aKsuv

#PharmaStrategy